This letter from CRAG (TB Community Research Advisors Group) and TAG was sent to Anne Whitaker, President, North America Pharmaceuticals of Sanofi US. It commends Sanofi for making this commitment to lower the price of rifapentine for Public Health Service (PHS) 340(b).
Open Letter: Appreciation for Sanofi US Committing to Lower Price of Rifapentine